Literature DB >> 3595703

Concentration of azapropazone in synovial tissues and fluid.

H Spahn, K Thabe, E Mutschler, K Tillmann, I Gikalov.   

Abstract

The concentration-time curves of azapropazone in synovial fluid and tissues have been studied in arthritic patients after an i.v. bolus (600 mg) and under steady-state conditions. Synovial fluid and tissue samples were taken intraoperatively 0.45-60 h after administration. The azapropazone concentrations in synovial fluid, synovial tissue and plasma were correlated. The levels in synovial fluid were usually lower than corresponding plasma levels. Under steady-state conditions azapropazone did not accumulate in synovial tissues.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3595703     DOI: 10.1007/bf00607579

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  10 in total

1.  The action of azapropazone, oxyphenbutazone and phenylbutazone on lysosomes.

Authors:  D A Lewis; R B Capstick; R J Ancill
Journal:  J Pharm Pharmacol       Date:  1971-12       Impact factor: 3.765

2.  Permeability of human synovial membrane to plasma proteins. Relationship to molecular size and inflammation.

Authors:  I Kushner; J A Somerville
Journal:  Arthritis Rheum       Date:  1971 Sep-Oct

Review 3.  Antirheumatic drug concentrations in human synovial fluid and synovial tissue. Observations on extravascular pharmacokinetics.

Authors:  W J Wallis; P A Simkin
Journal:  Clin Pharmacokinet       Date:  1983 Nov-Dec       Impact factor: 6.447

4.  [Transsynovial kinetics and correlation of dosage and effect of non-steroidal anti-rheumatic agents].

Authors:  H Fenner
Journal:  Fortschr Med       Date:  1982-09-23

5.  Investigation of phenylbutazone in synovial fluid.

Authors:  M Farr; J V Willis
Journal:  J Int Med Res       Date:  1977       Impact factor: 1.671

6.  Naproxen concentrations in serum, synovial fluid, and synovium.

Authors:  S Jalava; H Saarimaa; M Anttila; H Sundquist
Journal:  Scand J Rheumatol       Date:  1977       Impact factor: 3.641

7.  Transsynovial distribution of ibuprofen in arthritic patients.

Authors:  J B Whitlam; K F Brown; M J Crooks; G F Room
Journal:  Clin Pharmacol Ther       Date:  1981-04       Impact factor: 6.875

8.  [On the determination of azapropazone from plasma by direct quantitative thin-layer chromatography (author's transl)].

Authors:  H E Geissler; E Mutschler; G Faust-Tinnefeldt
Journal:  Arzneimittelforschung       Date:  1977

9.  Inhibition of anti-inflammatory drugs of prostaglandin production in cultured macrophages.

Authors:  K Brune; K D Rainsford; K Wagner; B A Peskar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-01       Impact factor: 3.000

10.  [Human pharmacokinetics of different i.v. doses of azapropazone (HPLC-determination) (author's transl)].

Authors:  I Gikalov; R Kaufmann; O Schuster
Journal:  Arzneimittelforschung       Date:  1982
  10 in total
  7 in total

Review 1.  Pharmacokinetics of nonsteroidal anti-inflammatory drugs in synovial fluid.

Authors:  R O Day; A J McLachlan; G G Graham; K M Williams
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

Review 2.  Recent findings on the pharmacokinetics of non-steroidal anti-inflammatory drugs in synovial fluid.

Authors:  P Netter; B Bannwarth; M J Royer-Morrot
Journal:  Clin Pharmacokinet       Date:  1989-09       Impact factor: 6.447

Review 3.  A comparison of synovial fluid concentrations of non-steroidal anti-inflammatory drugs with their in vitro activity.

Authors:  E Urquhart
Journal:  Agents Actions       Date:  1991-03

4.  Excretion of azapropazone in human breast milk.

Authors:  R Bald; E M Bernbeck-Betthäuser; H Spahn; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

5.  Effects of azapropazone on pain-related brain activity in human subjects.

Authors:  J Lötsch; P Mohammadian; T Hummel; S Florin; K Brune; G Geisslinger; G Kobal
Journal:  Br J Clin Pharmacol       Date:  1995-12       Impact factor: 4.335

6.  Effects of certain antiarthritic agents on the synthesis of type II collagen and glycosaminoglycans in rat chondrosarcoma cultures.

Authors:  G R Srinivas; C O Chichester; H J Barrach; A L Matoney
Journal:  Agents Actions       Date:  1994-05

7.  Tenoxicam concentrations in synovium and joint cartilage in humans.

Authors:  B Bannwarth; P Netter; F Lapicque; D Mainard; P Fener; P Gillet; A Gaucher
Journal:  Agents Actions       Date:  1991-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.